This article highlights individuals driving innovation and trust in various sectors. Shiva Sankeerth Reddy Yarradla is revolutionizing ente...

Indian technology hubs are becoming major innovation centers. Global companies anticipate AI will speed up new product and intellectual pro...

Amortisation is a number most investors skip, but it can shape reported profit. On the surface, it looks routine: A company spreads the cos...

A US agency abruptly closed an investigation into claims that Meta Platforms can access encrypted WhatsApp messages. A Commerce Department ...

The Delhi High Court will hear a plea from the Enforcement Directorate. The ED challenges a trial court's decision. The trial court refused...

India's higher education system faces an employability gap, with many graduates lacking job-ready skills. Vivekananda Global University (VG...

Biocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They...

The India-UK free trade agreement safeguards the interests of the Indian generic drugs industry. It does not allow patent extensions or dat...

Over 2.32 lakh patent applications were pending with the Indian Patent Office as on November 30 last year.

If a country feels that a provision or policy of another nation discriminates against its companies, it can challenge that under WTO's disp...

Section 3(d) is important because the government has a constitutional obligation to ensure that every citizen has access to healthcare.

The Indian Patent Office has hired 150 more examiners and is upgrading its bureaus nationwide as part of a move to expedite clearances.

Supreme Court on Wednesday deferred Swiss company Novartis' case against Indian government over the interpretation of Section 3 (d) of the ...

The PMO does not plan to seek any changes in two out of four key controversial provisions of the Indian patent law, which can compromise lo...

The humanitarian group Medecins Sans Frontieres (MSF, Doctors Without Borders) on Wednesday urged Swiss pharmaceutical group Novartis not t...

The Madras High Court dismissed a petition by Swiss pharmaceutical giant Novartis challenging the constitutionality of Section 3(d) of the ...

The wait could be longer than expected for the Madras High Court ruling on the controversial Glivec case.